BFC Planning’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RVMD
BFC Planning's RVMD Position: Q3 2026 in Review
BFC Planning increased its Revolution Medicines (RVMD) stake by 20% in Q3 2026, buying an estimated $13.7K and bringing the position to 418 shares worth $85.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1301.
BFC Planning first reported a position in RVMD in Q3 2024 and has held it in 9 quarters since. 590 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.
- BFC Planning held 418 shares of Revolution Medicines worth $85.8K as of Q3 2026.
- BFC Planning bought 69 Revolution Medicines shares in Q3 2026, an estimated $13.7K.
- Revolution Medicines made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #1301 holding.
- BFC Planning first reported a position in Revolution Medicines in Q3 2024 and has held it in 9 quarters since.
- 590 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.